A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci

• Sreekumar G. Pillai ,

  * E-mail: sreekumar.g.pillai@gsk.com (SGP); d.goldstein@duke.edu (DBG)

  Affiliation Genetics Division, GlaxoSmithKline Research and Development, Research Triangle Park, North Carolina, United States of America

  ⨯
• Dongliang Ge ,

  Contributed equally to this work with: Dongliang Ge, Guohua Zhu, Xiangyang Kong

  Affiliation IGSP Center for Population Genomics and Pharmacogenetics, Duke University, Durham, North Carolina, United States of America

  ⨯
• Guohua Zhu ,

  Contributed equally to this work with: Dongliang Ge, Guohua Zhu, Xiangyang Kong

  Affiliation Genetics Division, GlaxoSmithKline Research and Development, Research Triangle Park, North Carolina, United States of America

  ⨯
• Xiangyang Kong ,

  Contributed equally to this work with: Dongliang Ge, Guohua Zhu, Xiangyang Kong

  Affiliation Genetics Division, GlaxoSmithKline Research and Development, Research Triangle Park, North Carolina, United States of America

  ⨯
• Kevin V. Shianna,

  Affiliation IGSP Center for Population Genomics and Pharmacogenetics, Duke University, Durham, North Carolina, United States of America

  ⨯
• Anna C. Need,

  Affiliation IGSP Center for Population Genomics and Pharmacogenetics, Duke University, Durham, North Carolina, United States of America

  ⨯
• Sheng Feng,

  Affiliation IGSP Center for Population Genomics and Pharmacogenetics, Duke University, Durham, North Carolina, United States of America

  ⨯
• Craig P. Hersh,

  Affiliation Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
• Per Bakke,

  Affiliation University of Bergen, Bergen, Norway

  ⨯
• Amund Gulsvik,

  Affiliation University of Bergen, Bergen, Norway

  ⨯
• Andreas Ruppert,

  Affiliation Genetics Research Centre, Munich, Germany

  ⨯
• Karin C. Lødrup Carlsen,

  Affiliation Ullevaal University Hospital and the Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
• Allen Roses,

  Affiliations IGSP Center for Population Genomics and Pharmacogenetics, Duke University, Durham, North Carolina, United States of America, Deane Drug Discovery Institute, Duke University, Durham, North Carolina, United States of America

  ⨯
• Wayne Anderson,

  Affiliation Genetics Division, GlaxoSmithKline Research and Development, Research Triangle Park, North Carolina, United States of America

  ⨯
• ICGN Investigators,
• Stephen I. Rennard,

  Affiliation Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, United States of America

  ⨯
• David A. Lomas,

  Affiliation Cambridge Institute for Medical Research, Cambridge, United Kingdom

  ⨯
• Edwin K. Silverman,

  Affiliation Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
•  [ ... ],
• David B. Goldstein

  * E-mail: sreekumar.g.pillai@gsk.com (SGP); d.goldstein@duke.edu (DBG)

  Affiliation IGSP Center for Population Genomics and Pharmacogenetics, Duke University, Durham, North Carolina, United States of America

  ⨯
• [ view all ]
• [ view less ]